Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
US-2016375158-A1 · Dec 29, 2016 · US
involving radioactive labelled substances
involving radioactive labelled substances · Cooperative Patent Classification (CPC)
Computing, optics, measurement, and control technologies.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | G01N33/60 |
| Official title | involving radioactive labelled substances |
| Display label | involving radioactive labelled substances |
| Total patents | 385 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 26 |
| 2016 | 37 |
| 2017 | 33 |
| 2018 | 32 |
| 2019 | 55 |
| 2020 | 39 |
| 2021 | 39 |
| 2022 | 40 |
| 2023 | 23 |
| 2024 | 38 |
| 2025 | 17 |
| 2026 | 6 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Laser ablation cell
US-9496124-B2 · Nov 15, 2016 · US
Protein transduction domains mimics
US-2016324970-A1 · Nov 10, 2016 · US
Synthesis and use of isotopically labeled macrocyclic compounds
US-9482661-B2 · Nov 1, 2016 · US
Compounds and compositions for imaging gcc-expressing cells
US-2016303258-A1 · Oct 20, 2016 · US
Alkylphosphocholine analogs for multiple myeloma imaging and therapy
US-2016296646-A1 · Oct 13, 2016 · US
Compounds for Positron Emission Tomography
US-2016287731-A1 · Oct 6, 2016 · US
18f labeling of proteins using sortases
US-2016287734-A1 · Oct 6, 2016 · US
Method of overcoming therapeutic limitations of non-uniform distribution of radiopharmaceuticals and chemotherapy drugs
US-2016258963-A1 · Sep 8, 2016 · US
Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
US-2016228587-A1 · Aug 11, 2016 · US
Hyperpolarized lactate contrast agent for determination of LDH activity
US-9408925-B2 · Aug 9, 2016 · US
Pyridazinoindole compounds and methods for pet imaging
US-2016220704-A1 · Aug 4, 2016 · US
Heterocyclic molecules for biomedical imaging and therapeutic applications
US-2016213792-A1 · Jul 28, 2016 · US
Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
US-9393330-B2 · Jul 19, 2016 · US
Protein transduction domains mimics
US-9382366-B2 · Jul 5, 2016 · US
Hyperpolarized lactate contrast agent for determination of ldh activity
US-2016184462-A1 · Jun 30, 2016 · US
Immuno-pet imaging of antibodies and immunoconjugates and uses therefor
US-2016168261-A1 · Jun 16, 2016 · US
Enantiomeric separation and purification of 2,3,4,9-tetrahydro-1h-carbazole-4-carboxylic acid amide derivatives
US-2016168091-A1 · Jun 16, 2016 · US
Imaging tumor glycolysis by non-invasive measurement of pyruvate kinase m2
US-2016158389-A1 · Jun 9, 2016 · US
Absolute Quantitation of Proteins and Protein Modifications by Mass Spectrometry with Multiplexed Internal Standards
US-2016154006-A1 · Jun 2, 2016 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC G01N33/60?
- CPC G01N33/60 is the Cooperative Patent Classification code for “involving radioactive labelled substances.”
- How many patents are filed under CPC G01N33/60 (involving radioactive labelled substances)?
- Our database includes 385 publications tagged with this CPC code.
- Is patent activity under CPC G01N33/60 growing?
- Publication counts under this code: 38 in 2024 vs 17 in 2025 (latest complete years).